Randomized trial of two versus four years of adjuvant tamoxifen (AT) for postmenopausal women with node positive breast cancer

被引：0

作者：

Gallen, M ^{[1
]}

Alonso, C ^{[1
]}

Ojeda, B ^{[1
]}

Viladiu, P ^{[1
]}

Beltran, M ^{[1
]}

Borras, J ^{[1
]}

Pelegri, A ^{[1
]}

Tusquets, I ^{[1
]}

Barnadas, A ^{[1
]}

Arcusa, A ^{[1
]}

Bastus, R ^{[1
]}

Balil, A ^{[1
]}

Batiste-Alentorn, E ^{[1
]}

Boleda, M ^{[1
]}

Badia, MA ^{[1
]}

Garau, I ^{[1
]}

Guash, I ^{[1
]}

机构：

[1] Hosp Mar, Barcelona, Spain

来源：

EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷

关键词：

D O I：

10.1016/S0959-8049(97)89318-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P101

引用

页码：S40 / S40

页数：1

共 50 条

[21] ADJUVANT TAMOXIFEN IN POSTMENOPAUSAL BREAST-CANCER - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL
DELOZIER, T
JULIEN, JP
JURET, P
VEYRET, C
COUETTE, JE
GRAIC, Y
OLLIVIER, JM
DERANIERI, E
BREAST CANCER RESEARCH AND TREATMENT, 1986, 7 (02) : 105 - 110
[22] Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian Breast and Colorectal Cancer Study Group trial 6
Schmid, M
Jakesz, R
Samonigg, H
Kubista, E
Gnant, M
Menzel, C
Seifert, M
Haider, K
Taucher, S
Mlineritsch, B
Steindorfer, P
Kwasny, W
Stierer, M
Tausch, C
Fridrik, M
Wette, V
Steger, G
Hausmaninger, H
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) : 984 - 990
[23] Tamoxifen Plus Chemotherapy versus Tamoxifen Alone as Adjuvant Therapies for Node-Positive Postmenopausal Women with Early Breast CancerA Stochastic Economic Evaluation
Jonathan Karnon
Jackie Brown
PharmacoEconomics, 2002, 20 : 119 - 137
[24] ADJUVANT TREATMENT WITH TAMOXIFEN OF LYMPH-NODE-NEGATIVE BREAST-CANCER IN POSTMENOPAUSAL WOMEN
KURZ, C
SCHOLTEN, C
ZIELINSKI, C
CZERWENKA, K
KUBISTA, E
SPONA, J
SEVELDA, P
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1992, 117 (51-52) : 1943 - 1946
[25] RANDOMIZED TRIAL OF TAMOXIFEN VERSUS AMINOGLUTETHIMIDE AND VERSUS COMBINED TAMOXIFEN AND AMINOGLUTETHIMIDE IN ADVANCED POSTMENOPAUSAL BREAST-CANCER
ALONSOMUNOZ, MC
OJEDAGONZALEZ, MB
BELTRANFABREGAT, M
DORCARIBUGENT, J
LOPEZLOPEZ, L
BORRASBALADA, J
CARDENALALEMANV, F
GOMEZBATISTE, X
FABREGATMAYOL, J
VILADIUQUEMADA, P
ONCOLOGY, 1988, 45 (05) : 350 - 353
[26] Operabile breast cancer in postmenopausal women on adjuvant antiestrogen tamoxifen
Veselinovic, S
Filipovic, S
Projevic, M
Stojanovic, D
Buric, M
BALKAN CONGRESS OF ONCOLOGY, 1996, : 447 - 450
[27] Randomized comparison of adjuvant toremifene (Tor) versus tamoxifen (Tam) for postmenopausal women with node-positive (N plus ), estrogen receptor-positive (ER plus ) early stage breast cancer
不详
BREAST, 2005, 14 : S38 - S38
[28] Tamoxifen (T) vs tamoxifen plus uracil-ptegafur (T+UFT) in the adjuvant treatment of postmenopausal women with node positive breast cancer
Iglesias, L
Gomez, A
Moreno, A
Montano, A
Ruiz, M
Calvo, E
Pastor, P
Noguer, M
Barea, JL
Noguei, JAM
EUROPEAN JOURNAL OF CANCER, 1999, 35 : S207 - S207
[29] ASSESMENT OF QUALITY OF LIFE OF THE ADJUVANT TREATMENT WITH TAMOXIFEN VERSUS AROMATASE INHIBITORS AT WOMEN WITH BREAST CANCER - A RANDOMIZED TRIAL
Volovat, C.
Volovat, Simona Ruxandra
Dogaru, C.
Vulpoi, Carmen
MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2011, 115 (01): : 53 - 57
[30] A CONTROLLED TRIAL OF ADJUVANT TAMOXIFEN, WITH OR WITHOUT PREDNISOLONE, IN POSTMENOPAUSAL WOMEN WITH OPERABLE BREAST-CANCER
FENTIMAN, IS
HOWELL, A
HAMED, H
LEE, SM
RANSON, M
WALL, J
CHAUDARY, MA
ASH, CM
GREGORY, WM
SELLWOOD, RA
RUBENS, RD
BRITISH JOURNAL OF CANCER, 1994, 70 (04) : 729 - 731

← 1 2 3 4 5 →